The “1mg” case focuses on a key strategic dilemma of an entrepreneur in times of digitalization. Should 1mg be just an e-pharmacy and designed as pure pipeline business, a marketplace or be a hybrid between these two? Should it adhere to the current stakeholder constellation, or should the needs of patients, and no longer those of doctors and hospitals, be at the centre of the healthcare ecosystem? India’s healthcare market in 2014 was expected to grow with 14% CAGR reaching by 158B$. E-pharmacies not only enjoyed the support of the national government to reduce costs and improve quality of medication, but also to increase access to people in rural areas, comply with India regulation and increase sales tax collection. Traditional pharmacies were regulated under the Drug & Cosmetics Act whereas e-pharmacies were regulated under the IT Act. These different regulatory bases created distortion. It was expected that regulation would be clarified and give digitalization a strong boost. That said, the traditional brick and mortar pharmacies were still playing a critical role in the overall supply chain. At the same time a plethora of competitors were attracting funds by international venture capitalists and gain market traction, either based purely on new digital technologies or on their existing healthcare footprint. The case describes the different market segments based on demographics, health habits, age, and combines it with the penetration data of the mobile industry in the life of urban & rural Indians. The case also tackles the question of profitability versus growth and provides all the elements needed for a debate over the business model choice to be implemented.
Chinese EV leaders show how the Outpacing strategy uses fast evolutionary cycles to shift direction early and gain an edge over slower moving rivals.
But clinical psychologist Ingrid Clayton identifies a fourth survival strategy lurking in your neural circuitry that most leadership training misses – and it might be sabotaging your effectiveness.
Gloat’s Jeff Schwartz and Mike Worthington reveal how AI and skills-powered strategies are transforming talent management and workforce strategy.
Former Novo Nordisk CSO Marcus Schindler on R&D leadership, pharma innovation, scientific discovery, AI, global talent, DEI, biotech, drug development strategy.
Amy Bonsall and Alyson Meister show how to turn problems into opportunities through reframing your response to perceived threats.
Discover the new I by IMD Best Practice book series: four essential guides on leadership, strategy, governance, and sustainable transformation. Actionable insights from world-class faculty.
Gaming has become one of the world’s most powerful consumer ecosystems. Stefan Michel explores why every company now needs a strategy for play to stay competitive.
Explore the accelerating energy transition as IMD hosts RWE’s Kunal Chandra to discuss clean energy investment, bottlenecks, and strategic choices for leaders.
Vinted founder Milda Mitkute shares how she turned a wardrobe cleanout into Lithuania’s first tech unicorn and why responsible growth matters.
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications